UK markets open in 6 hours 48 minutes

Medigen Biotechnology Corp. (3176.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
39.10+0.40 (+1.03%)
At close: 01:30PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,028,724
1,157,720
1,055,947
3,922,012
615,541
Cost of revenue
1,136,709
540,391
968,487
1,370,698
351,894
Gross profit
1,892,015
617,329
87,460
2,551,314
263,647
Operating expenses
Research development
1,443,013
1,336,337
1,330,997
1,407,360
836,324
Selling general and administrative
385,037
499,642
402,306
376,606
341,301
Total operating expenses
1,828,050
1,835,979
1,733,303
1,783,966
1,177,625
Operating income or loss
63,965
-1,218,650
-1,645,843
767,348
-913,978
Interest expense
31,122
55,859
39,453
19,068
31,882
Income before tax
37,459
-1,278,860
-1,872,613
1,136,434
-880,006
Income tax expense
51,615
191,207
58,874
65,733
-32,634
Income from continuing operations
-14,156
-1,470,067
-1,931,487
1,070,701
-847,372
Net income
-243,544
-561,296
-675,874
-52,614
-337,923
Net income available to common shareholders
-243,544
-561,296
-675,874
-52,614
-337,923
Basic EPS
-4.27
-
-4.86
-0.38
-2.43
Diluted EPS
-4.27
-
-4.86
-0.38
-2.43
Basic average shares
139,146
-
139,069
138,970
138,988
Diluted average shares
139,146
-
139,069
138,970
138,988